Pharmaceuticals Native Starch Market Report 2026
Pharmaceuticals Native Starch Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pharmaceuticals Native Starch Market Report 2026

Global Outlook – By Type (Potato Starch, Corn Starch, Other Types), By Formulation Type (Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations), By Functionality (Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent), By Application (Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents), By End-User (Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharmaceuticals Native Starch Market Overview

• Pharmaceuticals Native Starch market size has reached to $6.11 billion in 2025

• Expected to grow to $9.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Increasing Prevalence Of Chronic Diseases Fuel Market Growth Due To Aging Populations Unhealthy Lifestyles And Environmental Factors

• Market Trend: Revolutionary Technological Advancements In The Evolution Of Starch Solutions

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceuticals Native Starch Market?

Pharmaceutical native starch is unaltered starch derived from natural sources such as corn, potato, wheat, or tapioca and utilized as an excipient in pharmaceutical formulations. It functions as a binder, disintegrant, or filler in tablets and capsules, helping to control medication release, increase stability, and maintain appropriate tablet formation without requiring chemical or physical change.

The main types of pharmaceutical native starches are potato starch, corn starch, and others. Potato starch, a fine, white powder derived from potato tubers, is known for its smooth texture and excellent binding properties, making it ideal for tablet formulations in pharmaceuticals. It is available in multiple formulation types, including oral solid dosage forms, liquid dosage forms, topical formulations, injectable drugs, and controlled-release formulations, for its functionality encompasses roles such as a texturizing agent, moisture retention agent, bulking agent, emulsifying agent, and film-forming agent. It is applied in various uses, including binders and coating agents, disintegrants, fillers and extenders, stabilizers, and thickening agents, catering to end-users, including pharmaceutical manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs), research and development laboratories, academic institutions, and others.

Pharmaceuticals Native Starch Market Global Report 2026 Market Report bar graph

What Is The Pharmaceuticals Native Starch Market Size and Share 2026?

The pharmaceuticals native starch market size has grown strongly in recent years. It will grow from $6.11 billion in 2025 to $6.64 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to availability of natural starch sources, expansion of generic pharmaceuticals, widespread use of tablets and capsules, cost sensitivity in drug formulation, regulatory acceptance of native starch.

What Is The Pharmaceuticals Native Starch Market Growth Forecast?

The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $9.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth in clean-label drug formulations, increasing sustainability requirements, expansion of pharmaceutical manufacturing in emerging markets, rising demand for biodegradable excipients, advancements in starch processing. Major trends in the forecast period include growing demand for natural and clean-label excipients, increasing use in solid oral dosage forms, rising adoption as binder and disintegrant, expansion of plant-based pharmaceutical ingredients, increasing focus on cost-effective excipients.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Pharmaceuticals Native Starch Market Segmentation

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Are The Drivers Of The Pharmaceuticals Native Starch Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the pharmaceuticals native starch market going forward. Chronic diseases are long-lasting medical conditions that typically progress slowly and persist for a year or more. The increasing prevalence of chronic diseases is primarily attributed to the rising aging population, as older individuals are more susceptible to long-term health conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more common with age. Pharmaceuticals native starch is helpful for chronic diseases by improving drug formulation stability, enhancing bioavailability, enabling controlled drug release, supporting patient compliance, and ultimately strengthening the effectiveness and long-term management of chronic medical conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of U.S. adults representing about 194 million people reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the increasing prevalence of chronic diseases is driving the growth of the pharmaceuticals native starch industry.

The expansion of generic drug manufacturing is expected to propel the growth of the pharmaceuticals native starch market going forward. Generic drug manufacturing refers to the production of off patent medications that are bioequivalent to branded drugs. Generic drug manufacturing is rising due to increasing regulatory support that speeds up approvals and encourages more companies to produce affordable alternatives to branded medicines. Expansion of generic drug manufacturing is supporting pharmaceuticals native starch by increasing the need for reliable, cost-effective excipients that enhance tablet formulation, stability, and drug delivery efficiency across a broader range of high-volume generic medicines. For instance, in November 2024, according to the Food and Drug Administration (FDA), a US-based federal agency, in FY 2023, the FDA approved 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Therefore, the expansion of generic drug manufacturing is driving the growth of the pharmaceuticals native starch industry.

Key Players In The Global Pharmaceuticals Native Starch Market

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Global Pharmaceuticals Native Starch Market Trends and Insights

Major companies operating in the pharmaceuticals native starch market are focusing on developing innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical properties derived from plant ingredients, such as thickness and gel strength, and helps pharmaceuticals use native starch by enhancing tablet binding, disintegration, and mouthfeel for improved natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional properties that enhance drug formulation performance, bioavailability, and controlled release while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.

Need data on a specific region in this market?

Regional Insights

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market consists of sales of sorghum starch, barley starch, sweet potato starch, and arrowroot starch. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceuticals Native Starch Market Report 2026?

The pharmaceuticals native starch market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceuticals native starch industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pharmaceuticals Native Starch Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.64 billion
Revenue Forecast In 2035 $9.23 billion
Growth Rate CAGR of 8.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Formulation Type, Functionality, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Lim
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pharmaceuticals Native Starch Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pharmaceuticals Native Starch Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pharmaceuticals Native Starch Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pharmaceuticals Native Starch Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Sustainability, Climate Tech & Circular Economy

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Biotechnology, Genomics & Precision Medicine

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Growing Demand For Natural And Clean-Label Excipients

4.2.2 Increasing Use In Solid Oral Dosage Forms

4.2.3 Rising Adoption As Binder And Disintegrant

4.2.4 Expansion Of Plant-Based Pharmaceutical Ingredients

4.2.5 Increasing Focus On Cost-Effective Excipients

5. Pharmaceuticals Native Starch Market Analysis Of End Use Industries

5.1 Pharmaceutical Manufacturers

5.2 Contract Manufacturing Organizations

5.3 Research And Development Laboratories

5.4 Academic Institutions

5.5 Nutraceutical Producers

6. Pharmaceuticals Native Starch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceuticals Native Starch Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmaceuticals Native Starch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pharmaceuticals Native Starch Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pharmaceuticals Native Starch Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pharmaceuticals Native Starch Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceuticals Native Starch Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceuticals Native Starch Market Segmentation

9.1. Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Potato Starch, Corn Starch, Other Types

9.2. Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

9.3. Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

9.4. Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

9.5. Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

9.6. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

9.7. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

9.8. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rice Starch, Wheat Starch, Tapioca Starch

10. Pharmaceuticals Native Starch Market Regional And Country Analysis

10.1. Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceuticals Native Starch Market

11.1. Asia-Pacific Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceuticals Native Starch Market

12.1. China Pharmaceuticals Native Starch Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceuticals Native Starch Market

13.1. India Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceuticals Native Starch Market

14.1. Japan Pharmaceuticals Native Starch Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceuticals Native Starch Market

15.1. Australia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceuticals Native Starch Market

16.1. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceuticals Native Starch Market

17.1. South Korea Pharmaceuticals Native Starch Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceuticals Native Starch Market

18.1. Taiwan Pharmaceuticals Native Starch Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceuticals Native Starch Market

19.1. South East Asia Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceuticals Native Starch Market

20.1. Western Europe Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceuticals Native Starch Market

21.1. UK Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceuticals Native Starch Market

22.1. Germany Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceuticals Native Starch Market

23.1. France Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceuticals Native Starch Market

24.1. Italy Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceuticals Native Starch Market

25.1. Spain Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceuticals Native Starch Market

26.1. Eastern Europe Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceuticals Native Starch Market

27.1. Russia Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceuticals Native Starch Market

28.1. North America Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceuticals Native Starch Market

29.1. USA Pharmaceuticals Native Starch Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceuticals Native Starch Market

30.1. Canada Pharmaceuticals Native Starch Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceuticals Native Starch Market

31.1. South America Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceuticals Native Starch Market

32.1. Brazil Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceuticals Native Starch Market

33.1. Middle East Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceuticals Native Starch Market

34.1. Africa Pharmaceuticals Native Starch Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Pharmaceuticals Native Starch Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceuticals Native Starch Market Regulatory and Investment Landscape

36. Pharmaceuticals Native Starch Market Competitive Landscape And Company Profiles

36.1. Pharmaceuticals Native Starch Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pharmaceuticals Native Starch Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pharmaceuticals Native Starch Market Company Profiles

36.3.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Roquette Frères SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Emsland Group Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceuticals Native Starch Market Other Major And Innovative Companies

Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

38. Global Pharmaceuticals Native Starch Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceuticals Native Starch Market

40. Pharmaceuticals Native Starch Market High Potential Countries, Segments and Strategies

40.1 Pharmaceuticals Native Starch Market In 2030 - Countries Offering Most New Opportunities

40.2 Pharmaceuticals Native Starch Market In 2030 - Segments Offering Most New Opportunities

40.3 Pharmaceuticals Native Starch Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Pharmaceuticals Native Starch Market, Overview Of Key Products - Product Examples
  • Table 2: Global Pharmaceuticals Native Starch Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Pharmaceuticals Native Starch Market, Supply Chain Analysis
  • Table 4: Global Pharmaceuticals Native Starch Market, Major Raw Material Providers
  • Table 5: Global Pharmaceuticals Native Starch Market, Major Resource Providers
  • Table 6: Global Pharmaceuticals Native Starch Market, Major Manufacturers (Suppliers)
  • Table 7: Global Pharmaceuticals Native Starch Market, Major Distributors And Channel Partners
  • Table 8: Global Pharmaceuticals Native Starch Market, Key Technologies & Future Trends
  • Table 9: Global Pharmaceuticals Native Starch Market, Major Trends
  • Table 10: Global Pharmaceuticals Native Starch Market, Major End Users
  • Table 11: Global Pharmaceuticals Native Starch Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Pharmaceuticals Native Starch Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Pharmaceuticals Native Starch Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Pharmaceuticals Native Starch Market - TAM, US$ Billion, 2025
  • Table 15: Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Pharmaceuticals Native Starch Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Pharmaceuticals Native Starch Market - Company Scoring Matrix
  • Table 99: Cargill Incorporated Financial Performance
  • Table 100: Archer Daniels Midland Company Financial Performance
  • Table 101: Ingredion Incorporated Financial Performance
  • Table 102: Roquette Frères SA Financial Performance
  • Table 103: Emsland Group Financial Performance
  • Table 104: Global Pharmaceuticals Native Starch Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Pharmaceuticals Native Starch Market, Competitive Dashboard
  • Table 106: Global Pharmaceuticals Native Starch Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Pharmaceuticals Native Starch Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Pharmaceuticals Native Starch Market Size Gain ($ Billion), Segmentation By Formulation Type, 2025 – 2030
  • Table 109: Global, Pharmaceuticals Native Starch Market Size Gain ($ Billion), Segmentation By Functionality, 2025 – 2030

List Of Figures

    Figure 1: Global Pharmaceuticals Native Starch Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Pharmaceuticals Native Starch Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Pharmaceuticals Native Starch Market, Supply Chain Analysis
  • Figure 4: Global Pharmaceuticals Native Starch Market, Major Raw Material Providers
  • Figure 5: Global Pharmaceuticals Native Starch Market, Major Resource Providers
  • Figure 6: Global Pharmaceuticals Native Starch Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Pharmaceuticals Native Starch Market, Major Distributors And Channel Partners
  • Figure 8: Global Pharmaceuticals Native Starch Market, Key Technologies & Future Trends
  • Figure 9: Global Pharmaceuticals Native Starch Market, Major Trends
  • Figure 10: Global Pharmaceuticals Native Starch Market, Major End Users
  • Figure 11: Global Pharmaceuticals Native Starch Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Pharmaceuticals Native Starch Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Pharmaceuticals Native Starch Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Pharmaceuticals Native Starch Market - TAM, US$ Billion, 2025
  • Figure 15: Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Pharmaceuticals Native Starch Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Pharmaceuticals Native Starch Market - Company Scoring Matrix
  • Figure 99: Cargill Incorporated Financial Performance
  • Figure 100: Archer Daniels Midland Company Financial Performance
  • Figure 101: Ingredion Incorporated Financial Performance
  • Figure 102: Roquette Frères SA Financial Performance
  • Figure 103: Emsland Group Financial Performance
  • Figure 104: Global Pharmaceuticals Native Starch Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Pharmaceuticals Native Starch Market, Competitive Dashboard
  • Figure 106: Global Pharmaceuticals Native Starch Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Pharmaceuticals Native Starch Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Pharmaceuticals Native Starch Market Size Gain ($ Billion), Segmentation By Formulation Type, 2025 – 2030
  • Figure 109: Global, Pharmaceuticals Native Starch Market Size Gain ($ Billion), Segmentation By Functionality, 2025 – 2030

Frequently Asked Questions

The Pharmaceuticals Native Starch market was valued at $6.11 billion in 2025, increased to $6.64 billion in 2026, and is projected to reach $9.23 billion by 2030. request a sample here

The global Pharmaceuticals Native Starch market is expected to grow at a CAGR of 8.6% from 2026 to 2035 to reach $9.23 billion by 2035. request a sample here

Some Key Players in the Pharmaceuticals Native Starch market Include, Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd. . request a sample here

Major trend in this market includes: Revolutionary Technological Advancements In The Evolution Of Starch Solutions. For further insights on this market. request a sample here

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Pharmaceuticals Native Starch Market Report 2026 market are Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquett request a sample here.

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts